HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toyohara, J. Articles by Fujibayashi, Y. Search for Related Content PubMed PubMed Citation Articles by Toyohara, J. Articles by Fujibayashi, Y.

Rationale of 5-¹²⁵I-Iodo-4'-Thio-2'-Deoxyuridine as a Potential Iodinated Proliferation Marker

¹ Research and Development Division, Research Center, Nihon Medi-Physics Company, Limited, Chiba, Japan
² School of Pharmaceutical Science, Showa University, Tokyo, Japan
³ Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan

The aim of this investigation was to synthesize and test a novel metabolically stable iodinated nucleoside as a proliferation-imaging agent for SPECT. Methods: 5-Iodo-4'-thio-2'-deoxyuridine (ITdU) and 5-iodo-1-(4-thio-ß-D-arabinofuranosyl)uracil (ITAU) were tested. The radiolabeling of ITdU and ITAU with ¹²⁵I was achieved by a destannylation reaction of the trimethylstannyl precursor of each nucleoside. The products were isolated in high yields and with >99% radiochemical purities. Results: ¹²⁵I-ITdU was effectively phosphorylated by cytosolic nucleoside kinases and specifically incorporated into a thymidine kinase-expressing L-M cell rather than a thymidine kinase-deficient mutant L-M (TK^-) cell. In addition, an in vitro cell metabolism study of ¹²⁵I-ITdU clarified that ¹²⁵I-ITdU was effectively and specifically incorporated into a DNA fraction (>90% at 60 min). Therefore, ¹²⁵I-ITdU was proven to be an ideal DNA synthesis marker such as 5-¹²⁵I-iodo-2'-deoxyuridine (IUdR). In contrast, ¹²⁵I-ITAU was neither remarkably phosphorylated by cytosolic nucleoside kinases nor notably incorporated into an L-M cell rather than an L-M (TK^-) cell. ¹²⁵I-ITdU and ¹²⁵I-ITAU showed a higher resistance to phosphorolytic cleavage by recombinant thymidine phosphorylase than did ¹²⁵I-IUdR. Furthermore, biodistribution of ¹²⁵I-ITdU and ¹²⁵I-ITAU revealed better in vivo stability of radioiodination than that of ¹²⁵I-IUdR. ¹²⁵I-ITdU also displayed a significantly higher uptake in proliferating organs (thymus, spleen, small intestine, and bone) than in nonproliferating organs (brain, muscle, liver, and lung), as did ¹²⁵I-IUdR, at 18 h after injection. As indicated by the in vitro study, ¹²⁵I-ITAU did not show any significant uptake in proliferating organs. Conclusion: Radioiodine-labeled ITdU is potentially useful as a proliferation-imaging agent, and further studies should clarify the usefulness of this compound as a tumor-imaging agent.

Key Words: 5-¹²⁵I-iodo-4'-thio-2'-deoxyuridine • 5-¹²⁵I-iodo-1-(4-thio-ß-D-arabinofuranosyl)uracil • 5-¹²⁵I-iodo-2'-deoxyuridine • nucleoside kinases • thymidine phosphorylase

This article has been cited by other articles:

				B. D. Zlatopolskiy, A. Morgenroth, F. H.-G. Kunkel, E. A. Urusova, C. Dinger, T. Kull, C. Lepping, and S. N. Reske Synthesis and Biologic Study of IV-14, a New Ribonucleoside Radiotracer for Tumor Visualization J. Nucl. Med., November 1, 2009; 50(11): 1895 - 1903. [Abstract] [Full Text] [PDF]

				A. Morgenroth, S. Deisenhofer, G. Glatting, F. H-G. Kunkel, C. Dinger, B. Zlatopolskiy, A. T.J. Vogg, T. Kull, and S. N. Reske Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]Iodo-4'-Thio-2'-Deoxyuridine Clin. Cancer Res., November 15, 2008; 14(22): 7311 - 7319. [Abstract] [Full Text] [PDF]

				S. N. Reske, S. Deisenhofer, G. Glatting, B. D. Zlatopolskiy, A. Morgenroth, A. T. J. Vogg, A. K. Buck, and C. Friesen 123I-ITdU-Mediated Nanoirradiation of DNA Efficiently Induces Cell Kill in HL60 Leukemia Cells and in Doxorubicin-, {beta}-, or {gamma}-Radiation-Resistant Cell Lines J. Nucl. Med., June 1, 2007; 48(6): 1000 - 1007. [Abstract] [Full Text] [PDF]

				J. Toyohara, K. Kumata, K. Fukushi, T. Irie, and K. Suzuki Evaluation of 4'-[Methyl-14C]Thiothymidine for In Vivo DNA Synthesis Imaging J. Nucl. Med., October 1, 2006; 47(10): 1717 - 1722. [Abstract] [Full Text] [PDF]

				J. Toyohara, A. Gogami, A. Hayashi, Y. Yonekura, and Y. Fujibayashi Pharmacokinetics and Metabolism of 5-125I-Iodo-4'-Thio-2'-Deoxyuridine in Rodents J. Nucl. Med., October 1, 2003; 44(10): 1671 - 1676. [Abstract] [Full Text] [PDF]